Schedule 13G ownership disclosure
Foghorn Therapeutics Inc
Security class unavailable · CUSIP: 344174107
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,139,639
- Percent of class
- 3.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-24-000526
- Form type
- SC 13G
- Filer
- Foghorn Therapeutics Inc.
- CIK
- CIK 1822462
- Filed
- Oct 08, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership